Transforming growth factor β1 (TGF-β1) is one of the most important fibrogenic factors promoting the activation of hepatic stellate cells (HScs). Autophagy is a process used by cells to degrade and recycle cellular proteins. Although TGF-β1 induces autophagy in several other cellular systems, the association between its effect on fibrogenesis and autophagy in HScs have not been determined. Liver tissues from c57BL/6 mice and the mouse HSc line JS1 were analyzed. Acute and chronic liver injury models were induced by carbon tetrachloride (ccl 4), and JS1 cells were stimulated by TGF-β1 to assess the mechanism and relationship between autophagy and fibrosis. Liver tissues from acute and chronic injury models induced by ccl 4 demonstrated evidence of increased autophagic activity, as assessed by the expression of the microtubule-associated protein 1 light chain 3BII protein. TGF-β1 stimulated the activation of JS1 cells and simultaneously increased autophagy flux. However, this effect was attenuated when autophagy was inhibited using chloroquine, 3-methyladenine or lentiviral short hairpin RNA-mediated knockdown of autophagy-related gene 7. Furthermore, whether MAPK, including ERK, JNK and p38 MAPK cascades were associated with TGF-β1-induced autophagy in JS1 cells was determined. Subsequently, it was shown that the ERK inhibitor, Pd98059, and JNK inhibitor, SP600125, were able to reverse TGF-β1-induced autophagy and fibrosis. The results of the present study suggest that TGF-β1-induced autophagy is involved in the activation of JS1 cells, possibly through activation of the ERK and JNK signaling pathways.